Kezar Life Sciences buy BiotechBee
Start price
07.09.22
/
80%
€9.70
Target price
31.12.24
€20.00
Performance (%)
-76.29%
End price
05.05.23
€2.30
Summary
This prediction ended on 05.05.23 with a price of €2.30. Massive losses of -76.29% were the result for the BUY prediction by BiotechBee. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kezar Life Sciences | - | - | - | - |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% | 63.917% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% | 91.986% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% | 83.957% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% | 71.357% |
According to BiotechBee what are the pros and cons of Kezar Life Sciences for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Kezar Life Sciences diskutieren
Buy mit Kursziel 20,0
In the thread Trading Kezar Life Sciences
Buy beendet

